GGrantIndex
← Leaderboards

Stanley A Thayer

University Of Minnesota

$12,545,104
Attributed
$12,545,104
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$12,545,104 · 10

By mechanism

R01$5,005,829 · 1
R37$3,133,448 · 1
R21$2,134,262 · 5
R33$1,214,589 · 1
P50$1,056,976 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Minnesota

Same institution · by research overlap

Others in their field

Top investigators on “Neurons

Research focus

NeuronsSynapsesCannabinoidsPharmaceutical PreparationsExposure ToAffectBaseNeurotoxicityHiv-1FoundationsImpaired CognitionGlutamatesProteinsFundingPostsynapticNeurodegenerative DisordersHippocampus (Brain)InsightImageExcitatory SynapseCellsEndocannabinoidsPathway InteractionsMicroglia

Grant awards (45)

HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$460,054
R01 · FY2024 · DA · contact PI
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$460,054
R01 · FY2023 · DA · contact PI
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$460,054
R01 · FY2022 · DA · contact PI
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$459,312
R01 · FY2021 · DA · contact PI
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$457,086
R01 · FY2020 · DA · contact PI
Antiretroviral Drug-Induced Changes in Synapses between Human iPSC-Derived Cortical Neurons to Assess Risk and Mechanisms of Neuropsychiatric Adverse Effects$192,500
R21 · FY2020 · MH · contact PI
Antiretroviral Drug-Induced Changes in Synapses between Human iPSC-Derived Cortical Neurons to Assess Risk and Mechanisms of Neuropsychiatric Adverse Effects$231,000
R21 · FY2019 · MH · contact PI
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$380,000
R01 · FY2018 · DA · contact PI
Synapse loss induced by HIV-1 proteins in the presence of ART and drugs of abuse$192,396
R21 · FY2018 · DA · contact PI
Scalable assay for drugs to reverse synapse loss during HIV-1 neurotoxicity$636,626
R33 · FY2017 · NS · contact PI
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$380,000
R01 · FY2017 · DA · contact PI
Synapse loss induced by HIV-1 proteins in the presence of ART and drugs of abuse$229,375
R21 · FY2017 · DA · contact PI
Scalable assay for drugs to reverse synapse loss during HIV-1 neurotoxicity$577,963
R33 · FY2016 · NS · contact PI
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$376,200
R01 · FY2016 · DA · contact PI
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$374,300
R01 · FY2015 · DA · contact PI
Scalable assay for drugs to reverse synapse loss during HIV-1 neurotoxicity$195,601
R21 · FY2015 · NS · contact PI
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids$380,000
R01 · FY2014 · DA · contact PI
Scalable assay for drugs to reverse synapse loss during HIV-1 neurotoxicity$268,750
R21 · FY2014 · NS · contact PI
Pharmacological modulation of synapses and cognition during HIV-1 neurotoxicity$190,000
R21 · FY2014 · DA · contact PI
HIV Neurotoxicity-Mechanism & Modulation by Cannabinoids$313,212
R37 · FY2013 · DA · contact PI
Pharmacological modulation of synapses and cognition during HIV-1 neurotoxicity$228,000
R21 · FY2013 · DA · contact PI
HIV Neurotoxicity-Mechanism & Modulation by Cannabinoids$326,263
R37 · FY2012 · DA · contact PI
Effects of Chronic Opiates on Endocannabinoid Signaling at Excitatory Synapses$170,011
P50 · FY2012 · DA · contact PI
HIV Neurotoxicity-Mechanism & Modulation by Cannabinoids$326,263
R37 · FY2011 · DA · contact PI
Effects of Chronic Opiates on Endocannabinoid Signaling at Excitatory Synapses$170,511
P50 · FY2011 · DA · contact PI
HIV Neurotoxicity-Mechanism & Modulation by Cannabinoids$336,353
R37 · FY2010 · DA · contact PI
Effects of Chronic Opiates on Endocannabinoid Signaling at Excitatory Synapses$56,443
P50 · FY2010 · DA · contact PI
HIV Neurotoxicity-Mechanism & Modulation by Cannabinoids$364,750
R37 · FY2009 · DA · contact PI
Effects of Chronic Opiates on Endocannabinoid Signaling at Excitatory Synapses$59,474
P50 · FY2009 · DA · contact PI
HIV Neurotoxicity-Mechanism & Modulation by Cannabinoids$275,977
R37 · FY2008 · DA · contact PI
Cannabinoid Modulation of Recovery from HIV-Associated Synaptic Toxicity$219,765
R21 · FY2008 · DA · contact PI
Effects of Chronic Opiates on Endocannabinoid Signaling at Excitatory Synapses$73,992
P50 · FY2008 · DA · contact PI
HIV Neurotoxicity-Mechanism & Modulation by Cannabinoids$281,609
R37 · FY2007 · DA · contact PI
Cannabinoid Modulation of Recovery from HIV-Associated Synaptic Toxicity$186,875
R21 · FY2007 · DA · contact PI
Cannabinoid Modulation of Synaptic Transmission$118,080
P50 · FY2007 · DA · contact PI
HIV Neurotoxicity-Mechanism & Modulation by Cannabinoids$290,021
R37 · FY2006 · DA · contact PI
HIV Neurotoxicity-Mechanism &Modulation by Cannabinoids$297,000
R37 · FY2005 · DA
HIV Neurotoxicity-Mechanism &Modulation by Cannabinoids$322,000
R37 · FY2004 · DA
HIV NEUROTOXICITY--MECHANISM &MODULATION BY CANABINOIDS$213,855
R01 · FY2003 · DA
HIV NEUROTOXICITY--MECHANISM &MODULATION BY CANABINOIDS$207,627
R01 · FY2002 · DA
CANNABINOID MODULATION OF SYNAPTIC TRANSMISSION$0
P50 · FY2002 · DA
HIV NEUROTOXICITY--MECHANISM &MODULATION BY CANABINOIDS$201,580
R01 · FY2001 · DA
CANNABINOID MODULATION OF SYNAPTIC TRANSMISSION$0
P50 · FY2001 · DA
CANNABINOID MODULATION OF SYNAPTIC TRANSMISSION$408,465
P50 · FY2000 · DA
HIV NEUROTOXICITY--MECHANISM &MODULATION BY CANABINOIDS$195,707
R01 · FY2000 · DA